XBP Global Appoints Acquelia Colaco as Chief Human Resources OfficerXBP Global Holdings, Inc. (“XBP Global” or “the Company”) (NASDAQ: XBP), announced the appointment of Acquelia Colaco as its Chief Human Resources Officer (CHRO).Acquelia will lead the global people’s agenda across the Americas, Europe, and Asia, with a mandate to align talent, leadership, and culture to this next phase of AI-led transformation.IRVING, Texas, April 22, 2026 (GLOBE NEWSWIRE) — XBP Global Holdings, Inc. (“XBP Global” or “the Company”) (NASDAQ: XBP), a multinational technology and services company orchestrating mission-critical systems that enable hyper-automation and digital transformation, announced the appointment of Acquelia Colaco as its Chief Human Resources Officer (CHRO). Acquelia will lead the global people’s agenda across...

BOCA RATON, Fla., April 22, 2026 (GLOBE NEWSWIRE) — Red Violet, Inc. (NASDAQ: RDVT), a leading analytics and information solutions provider, announced today that it will report its financial results for the first quarter ended March 31, 2026 after the close of the U.S. financial markets on Wednesday, May 6, 2026. The Company will host its earnings call on Wednesday, May 6, 2026, at 4:30pm ET to discuss its quarterly results and provide a business update. The participant registration and webcast information are listed below. The earnings call will be simultaneously webcast on the Investors section of the red violet website at www.redviolet.com. Please login at least 15 minutes prior to the start of the call to ensure adequate time for any downloads that may be required. Please note participants must register to receive their unique...

CAMPBELL, Calif., April 22, 2026 (GLOBE NEWSWIRE) — Arteris, Inc. (Nasdaq: AIP), a leading provider of semiconductor technology for accelerating innovation in the AI era, today announced it will release its financial results for the first quarter ended March 31, 2026, after market close on Tuesday, May 12, 2026. Management will host a conference call on Tuesday, May 12, 2026, at 4:30 PM ET to discuss these results. The call will be available, live, to interested parties by dialing:United States/Canada Toll Free: +1-800-717-1738International Toll: +1-646-307-1865   Please join the call 5-10 minutes prior to the scheduled start time to avoid a delay in connecting. A live webcast will be available in the Investor Relations section of Arteris’ website at: https://ir.arteris.com/events-and-presentations. A replay of the webcast...

CONSHOHOCKEN, Pa., April 22, 2026 (GLOBE NEWSWIRE) — Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) announced today that it will release its first-quarter 2026 financial results on Wednesday, May 6, 2026, prior to the open of the U.S. financial markets. Following the announcement, Madrigal’s management will host a live webcast at 8 a.m. Eastern Time to review the Company’s financial and operating results. The live webcast may be accessed at the Investor Relations section of the Madrigal Pharmaceuticals website. To ensure a timely connection, it is recommended that participants register at least 15 minutes prior to the scheduled webcast. The webcast will be available approximately two hours after the live webcast. About Madrigal PharmaceuticalsMadrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) is a biopharmaceutical company focused on...

MCDONALD, Tenn., April 22, 2026 (GLOBE NEWSWIRE) — Amaero Ltd (ASX:3DA, OTCX:AMROF) (“Amaero” or the “Company”), a leading producer of high-value refractory and titanium alloy powders for additive and advanced manufacturing, and a leader in PM-HIP (Powder Metallurgy Hot Isostatic Pressing) manufacturing, is pleased to share a recording of the Investor Webinar held on April 20, 2026 at 9:00 pm ET. Shareholders can view the recording here: https://investorhub.amaero.com.au/activity-updates/P7pJEy-amaero-ltd-asx-3da-investor-webinar-21-april-2026 This announcement has been authorized for release by the Chairman and CEO. For further information, please contact:Amaero LtdHank J. Holland Chairman and CEOhank.holland@amaeroinc.com Media & Investor Enquiries in AustraliaJane Morgan Directorjm@janemorganmanagement.com.au Media &...

Rich Heyman to retire from PMV Pharma Board of Directors; Laurie Stelzer, Director since 2020, appointed as new Chair PRINCETON, N.J., April 22, 2026 (GLOBE NEWSWIRE) — PMV Pharmaceuticals, Inc. (“PMV Pharma” or the “Company”; Nasdaq: PMVP), a precision oncology company pioneering the discovery and development of small molecule therapies targeting p53, today announced a leadership transition on its Board of Directors. Laurie Stelzer, who has served as a member of the Board since 2020, has been appointed Chair of the Board, succeeding Rich Heyman, Ph.D., effective at the Company’s 2026 Annual Meeting of Stockholders on June 4, 2026 (the “Meeting”). Dr. Heyman’s term as a member and Chair of the Board will expire at the Meeting, and Dr. Heyman will not stand for reelection. Ms. Stelzer brings more than 25 years of senior finance and...

Company has invested greater than 10% of its investable capital in the convergence of Artificial Intelligence (“AI”) and space through Astro Capital NORTH PALM BEACH, Fla., April 22, 2026 (GLOBE NEWSWIRE) — SRx Health Solutions, Inc. (NYSE American: SRXH) (the “Company”) and EMJ Crypto Technologies (“EMJX”), a digital-asset treasury operating platform with which the Company has entered into a definitive merger agreement, today announced it has made an investment of greater than 10% of its investable capital in Astro Investment XVII, an affiliate of Astro Capital and special purpose vehicle (SPV). For more information please visit, Astro Capital. “This investment demonstrates our belief in the long-term value of both AI and space,” said Eric. M. Jackson, EMJX Founder & Chief Executive Officer. “Astro...

GUANGZHOU, China, April 22, 2026 (GLOBE NEWSWIRE) — Pony AI Inc. (“Pony.ai” or the “Company”) (NASDAQ: PONY; HKEX: 2026), a global leader in achieving large-scale mass production and commercialization of autonomous driving technology, today announced that it will hold an annual general meeting of the Company’s shareholders (the “AGM”) at 10:00 a.m. (Beijing time) on June 8, 2026 at 1/F, Building 8, Phase II, Datang Industrial Park, Huangge Town, Nansha District, Guangzhou, Guangdong Province, PRC, for the purposes of considering and, if thought fit, passing each of the Proposed Resolutions as defined and set forth in the notice of the AGM (the “AGM Notice”). A circular of the Company dated April 22, 2026 in relation to the AGM, the AGM Notice and the form of proxy for the AGM are available on the Company’s website at https://ir.pony.ai....

GUANGZHOU, China, April 22, 2026 (GLOBE NEWSWIRE) — Pony AI Inc. (“Pony.ai” or the “Company”) (NASDAQ: PONY; HKEX: 2026), a global leader in achieving large-scale mass production and commercialization of autonomous driving technology, today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2025, with the U.S. Securities and Exchange Commission (the “SEC”). The annual report can be accessed on the Company’s investor relations website at https://ir.pony.ai. The Company will provide a hard copy of its annual report containing the audited consolidated financial statements, free of charge, to its shareholders and ADS holders upon request. Requests should be directed to the Company’s Investor Relations Department at ir@pony.ai. The Company today also announced that it published its inaugural...

AON leaders to speak on panels focused on advocacy, innovation and access in independent community oncology FORT MYERS, Fla., April 22, 2026 (GLOBE NEWSWIRE) — American Oncology Network (AON), one of the nation’s fastest-growing community oncology networks, today announced it will participate in 11 speaking sessions at the 2026 Community Oncology Alliance (COA) Annual Conference. The event, themed Innovation in Practice, will take place April 28-29 in Orlando, Florida.“At AON, we are committed to advancing community oncology through innovation that supports local practices and improves patient outcomes,” said Stephen “Fred” Divers, MD, AON’s chief medical officer, medical oncologist at Genesis Cancer and Blood Institute, and officer-at-large on COA’s Executive Committee. “The conference provides an important platform to share...